Results 41 to 50 of about 4,852,229 (166)

Case of a young girl with marked bone marrow plasmacytosis

open access: yesSri Lanka Journal of Medicine, 2021
Marked plasmacytosis in the bone marrow is a rare finding in young people. If present it is secondary to an underlying disease condition. Castleman disease is a rare form of lymphoproliferative disorder. Due to its rarity, it is not frequently considered
V. C. Panditha Gunwardena   +4 more
doaj   +1 more source

Castleman Disease; A Rare Mass of Neck [PDF]

open access: yes, 2020
Castleman hastalığı, lenfoproliferatif hastalıkların heterojen bir grubu olup tek bir hastalık olarak düşünülmemelidir. Bu hastalık çeşitli klinik şekillerde ortaya çıkmaktadır.
Güçlü, Oğuz   +4 more
core   +1 more source

Long‐Term Outcomes After Elective Splenectomy for Haematological Disease: A 27‐Year Single‐Centre Study

open access: yesANZ Journal of Surgery, EarlyView.
Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett   +9 more
wiley   +1 more source

Early tocilizumab and outcomes in acute necrotizing encephalopathy

open access: yesDevelopmental Medicine &Child Neurology, EarlyView.
Early tocilizumab and outcome in acute necrotising encephalopathy. Aim To evaluate the timing and safety of tocilizumab in acute necrotizing encephalopathy (ANE). Method This was a multicentre retrospective study evaluating outcomes (modified Rankin Scale [mRS]) in children with ANE treated with tocilizumab. A logistic regression model determined a cut‐
Velda X Han   +14 more
wiley   +1 more source

Comparison of intestinal histopathological changes following teclistamab, BCMA‐directed CAR T, CD19‐directed CAR T and rituximab therapies

open access: yesHistopathology, EarlyView.
This is a retrospective review of intestinal tract biopsies from patients treated with various cellular immunotherapies (BCMA and CD19‐directed CAR T, teclistamab and rituximab therapies). We found distinct but overlapping histologic patterns across treatment groups, with lamina propria plasma cell depletion, crypt apoptotic bodies and active ...
Olivia J Leung   +7 more
wiley   +1 more source

Castleman disease [PDF]

open access: yes, 2005
Castleman disease or giant lymph node hyperplasia, is a rare disorder that is located most commonly in the visceral mediastinum. We report a Castleman disease represented with hilar lymph node hyperplasia. Diagnosis and treatment of this rare disorder is

core  

Idiopathic multicentric Castleman disease: A case report

open access: yesAsian Journal of Medical Sciences
Castleman disease is a rare disease affecting lymph nodes and is considered a non-clonal lymphoproliferative disorder. It has variable clinical presentation and is divided into clinical and histopathological subtypes.
Anna John , Sheima R Das
doaj   +1 more source

HIV-associated multi-centric Castleman’s disease with multiple organ failure: cuccessful treatment with rituximab [PDF]

open access: yes, 2010
Introduction: Multicentric Castleman's Disease (MCD), a lymphoproliferative disorder associated with Human Herpes Virus-8 (HHV-8) infection, is increasing in incidence amongst HIV patients.
Johns, RH   +7 more
core  

Human Herpesvirus 8 Causes a Wide Spectrum of Disease in Liver Transplant Recipients and May be Donor Derived: Case Series and Systematic Review of an Emerging Challenge

open access: yesTransplant Infectious Disease, EarlyView.
Among 135 cases of post‐liver transplant HHV8 disease (4 from NSW), presentations varied, and mortality was high (44%). Donor screening was rare, and donor‐derived infection was suspected in 33%. Survival improved with mTORi, reduced immunosuppression, chemotherapy, and, for non‐KS disease, donor screening. ABSTRACT Background Human herpesvirus 8 (HHV8)
Karen M. J. Waller   +12 more
wiley   +1 more source

Castleman disease. A rare clinical case of retroperitoneal tumor localization in an elderly patient

open access: yesActa Biomedica Scientifica, 2023
Castleman disease is an extremely rare benign disease of the lymphatic system with an estimated incidence of 1–9 cases per 1,000,000. Its etiology remains unknown; interleukin 6 (IL-6) plays an important role in pathogenesis.
M. B. Polyanskiy   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy